title: Experimental subchronic mycotoxicoses in mice: individual and combined effects of dietary exposure to fumonisins and aflatoxin B1.
abstract: We have used a murine model of subchronic mycotoxicoses produced by ingestion of mycotoxins. The five groups of animals studied were fed for 30, 60 and 90 days, respectively, with commercial diet (CD), experimental control diet (ECD), experimental with fumonisin B1 diet (EFD) and experimental with mixtures of mycotoxins diet (EMD). The animals fed EFD and EMD showed a significant increase in feed consumption/day with respect to the animals fed ECD (P < 0.005 for both groups). The biochemical measurements showed significant differences at 90 days in those animals fed EAD exhibiting a marked decrease in the values of alkaline phosphatase (ALP) and cholesterol (P < 0.05), along with a significant increase in calcium (P < 0.01). Differences in the decrease of the parameters studied were observed in mice fed EFD for triglycerides, cholesterol and calcium (P < 0.05 for all of them). The activity of aspartate transaminase (AST) increased significantly in animals fed EMD (P < 0.01). The tissue specimens at 60 days showed lesions in the livers of the animals fed EAD and EFD. At 90 days, and in those fed EAD, EFD and EMD, the lesions were intensified in the liver at 60 days in 80, 90 and 100% of the animals, respectively.
authors.affiliation: Micología, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Ciudad Universitaria, 5000, Cordoba, Argentina.
authors.forename: J M
authors.initials: JM
authors.lastname: Casado
authors.forename: M
authors.initials: M
authors.lastname: Theumer
authors.forename: D T
authors.initials: DT
authors.lastname: Masih
authors.forename: S
authors.initials: S
authors.lastname: Chulze
authors.forename: H R
authors.initials: HR
authors.lastname: Rubinstein
mesh_terms: D016604:Aflatoxin B1 / Q000008:administration & dosage / Q000633:toxicity*; D000469:Alkaline Phosphatase / Q000097:blood; D000821:Animal Feed; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001835:Body Weight / Q000187:drug effects; D002118:Calcium / Q000097:blood; D002264:Carboxylic Acids / Q000008:administration & dosage / Q000633:toxicity*; D002784:Cholesterol / Q000097:blood; D004195:Disease Models, Animal; D004435:Eating / Q000187:drug effects; D005506:Food Contamination; D037341:Fumonisins; D007421:Intestine, Small / Q000187:drug effects / Q000473:pathology; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008297:Male; D051379:Mice; D015651:Mycotoxicosis / Q000209:etiology*; D014280:Triglycerides / Q000097:blood
chemical_list: D002264:Carboxylic Acids; D037341:Fumonisins; D014280:Triglycerides; C056933:fumonisin B1; D002784:Cholesterol; D016604:Aflatoxin B1; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D002118:Calcium